NOT-CA-21-077: Notice of Correction of Key Dates for PAR-20-284, Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)

Notice of Correction of Key Dates for PAR-20-284, Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)

Notice Number:

NOT-CA-21-077

Key Dates

Release Date:

May 4, 2021

Related Announcements

PAR-20-284 - Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Key Dates for PAR-20-284, Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed).

Part 1. Key Dates

Currently reads:

Application Due Date(s): November 4, 2020, May 6, 2021, November 4, 2021, May 5, 2021, November 3, 3022, May 4, 2023

Modified to read (in italics):

Application Due Date(s): November 4, 2020, May 6, 2021, November 4, 2021, May 5, 2022, November 3, 2022, May 4, 2023

All other aspects of PAR-20-284 remain unchanged.

Inquiries

Please direct all inquiries to:

Piotr Grodzinski, Ph.D.
National Cancer Institute (NCI)
Telephone 240-781-3305
Email: grodzinp@mail.nih.gov

Christopher Hartshorn, Ph.D.
National Cancer Institute (NCI)
Telephone 240-781-3315
Email: christopher.hartshorn@nih.gov

Christina Liu, Ph.D.
National Cancer Institute (NCI)
Telephone 240-781-3348
Email: christina.liu@nih.gov

Crystal Wolfrey
National Cancer Institute (NCI)
240-276-6277
Email: wolfreyc@mail.nih.gov